Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Roche
Roche
Page 3 of 4
Newsletters
The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health
By
Investment Desk
August 16, 2019
Health
Roche Bids $4.8 Billion for U.S.-Based Gene Therapy Specialist Spark
By
Tim Loh
,
Naomi Kresge
and
Bloomberg
February 25, 2019
Health
The FDA Approved the First Big New Flu Drug in Almost 20 Years—And Is Approaching a Drug Approval Record
By
News Correspondent
October 24, 2018
Health
How to Innovate at Flatiron Health? It Starts With a Hackathon
By
Senior Editor
July 31, 2018
Health
Japan Just Approved a New Drug That Can Kill the Flu Virus In Just One Day
By
Financial Writer
February 23, 2018
Health
Why Drug Giant Roche’s $1.9 Billion Deal to Buy Data Startup Flatiron Health Matters
By
Tech Reporter
February 16, 2018
Finance
Roche to Buy U.S. Cancer Drugmaker Ignyta for $1.7 Billion
By
Blockchain Reporter
December 22, 2017
Health
A ‘Groundbreaking’ New Drug Shows Promise Against Huntington’s—But There’s a Catch
By
Trading Desk
December 11, 2017
Health
Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?
By
Crypto Correspondent
September 15, 2017
Health
Roche Loses Billions in Value After Pricey Breast Cancer Drug Combo Disappoints
By
News Correspondent
June 5, 2017
Health
The FDA Just Approved the First Ever Drug to Treat Severe MS
By
Market Analyst
March 29, 2017
Leadership
This Big Pharma CEO Thinks Trump’s Drug Pricing Threats Are All Bark and No Bite
By
Crypto Correspondent
February 2, 2017
Health
The FDA Has Issued Emergency Authorization for Roche’s Zika Test
By
Reuters
and
Michelle Toh
August 29, 2016
Health
Here’s Why HPV-Related Cancers Are Rising Among American Men
By
News Correspondent
July 8, 2016
Health
These Are the Most Promising Experimental Cancer Drugs
By
Digital Assets Editor
June 9, 2016
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
News Correspondent
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Industry Analyst
Travel & Leisure
Transportation chief offers advice to increasingly angry Americans: ‘Let’s maybe go back to an era where we didn’t wear...
By
Market Analyst